Nausea, Appetite and Cannabis: What Recent Science Says

Overview of the Evidence

All the studies discussed here come from PubMed, the U.S. National Library of Medicine’s database of peer‑reviewed research. They provide a snapshot of what scientists have examined about nausea, appetite and cannabis, but the science is still developing. The information below is intended for general education and is not medical advice. If you are considering cannabis for symptoms, talk to a licensed physician first.

1. Gastroparesis and Nausea: A Baseline for Discussion

A review published in JAMA examined a large U.S. health‑insurance claims database to estimate how common gastroparesis is. The study found a prevalence of 21.5 cases per 100,000 people, with a higher rate in females. Gastroparesis is characterized by delayed gastric emptying and typically produces nausea, vomiting, and early fullness after eating. This review highlights the significance of nausea in a real‑world population and sets the stage for considering how other treatments might affect these symptoms. View study

2. Cannabinoids and Chemotherapy‑Induced Nausea

A comprehensive review in Current Medicinal Chemistry described the diversity of cannabinoids found in Cannabis sativa, including over 480 different compounds and 110 phytocannabinoids. It noted that several synthetic derivatives, such as nabilone, are approved for use in cancer patients to relieve nausea triggered by chemotherapy. The authors emphasized that cannabinoids act through multiple pathways, but detailed mechanisms remain under investigation. View review

Key Takeaway

• Commercially available cannabinoid derivatives are already licensed for chemotherapy‑related nausea.
• Natural cannabis products may contain similar compounds, but their effects can vary widely.

3. Appetite and Cannabinoids: What the Science Says

While no single PubMed study in our list focuses solely on appetite, the same review in Current Medicinal Chemistry discusses how cannabinoids interact with the body’s endocannabinoid system, which plays a role in hunger regulation. Researchers have observed that cannabinoids can influence appetite in animal models, but human data are less clear. The review cautions that translating these findings to everyday use requires more evidence. Read more

4. Cannabinoids for Chemotherapy‑Induced Peripheral Neuropathy

A systematic review in the Journal of Pain & Palliative Care Pharmacotherapy evaluated randomized controlled trials that tested cannabis‑based medicinal products (CBMPs) for preventing or treating peripheral neuropathy caused by chemotherapy. The authors found that while preclinical data suggested potential benefits, the clinical evidence remained inconclusive. Some trials reported modest pain relief, but side effects and study limitations prevented firm conclusions. See study

Implication for Nausea and Appetite

• CBMPs may help with pain, but their impact on nausea or appetite has not been clearly demonstrated in these studies.
• Patients experiencing neuropathy may still benefit from other supportive care measures.

5. Cannabidiol and Cognitive Function: A Related Insight

In Cancer Letters, researchers examined breast‑cancer patients receiving chemotherapy and found that cannabidiol (CBD) could reduce chemotherapy‑induced cognitive decline. Although the study focused on brain function, it highlighted CBD’s anti‑inflammatory properties, which might also influence gastrointestinal symptoms. However, the authors noted that clinical evidence is preliminary and further research is needed. Explore the article

6. Safety and Psychiatric Aspects of CBD Products

A review in Der Nervenarzt surveyed the benefits and risks of commercially available CBD products. The authors reported that, aside from rare side effects, CBD is generally well tolerated. They also discussed the limited evidence for psychiatric outcomes, noting that more studies are required to understand how CBD might affect mood or anxiety when used for nausea or appetite. Read the review

7. Emerging Plant‑Based Therapies: A Broader Context

While not directly about cannabis, a paper in Molecular Biotechnology reviewed phytochemical therapies for cancers linked to viral infections. The authors discussed how plant compounds could modulate immune responses, an area of interest for researchers exploring cannabis’s immunomodulatory effects. The study underscores the complexity of plant‑based treatments and the need for rigorous testing. View the paper

Putting the Pieces Together

Collectively, these studies suggest that cannabis and its derivatives are being explored for nausea, especially in cancer care, and that cannabinoids interact with systems governing appetite and pain. Evidence for appetite enhancement is still emerging, and the safety profile of both natural and synthetic cannabinoids warrants careful consideration. The field of cannabis research is evolving, and each new study adds to a growing understanding rather than providing definitive answers.

Next Steps for Patients

If you are dealing with nausea or appetite issues, these findings can inform a conversation with your healthcare provider. Discuss your symptoms, medical history, and any current medications, and ask whether cannabis‑based therapies might be appropriate for you. Your provider can help weigh the potential benefits against the risks and guide you toward the best evidence‑based approach.

Remember, the information above is for educational purposes only and should not replace personalized medical advice.